Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
Yasushi Kondo(Keio University), Kenji Nakanishi(Japan Science and Technology Agency), Shizue Futatsugi‐Yumikura(Japan Science and Technology Agency), Nobuki Hayashi(Japan Science and Technology Agency), Mai Morimoto(Hyogo Medical University), Tomohiro Yoshimoto(Hyogo Medical University), Jiro Fujimoto(Harvard University), Tomoyuki Hoshino(Kurume University), Koubun Yasuda(Hyogo Medical University)
Cited by 480
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Interleukin-18 in Health and Disease
|International Journal of Molecular Sciences|2019|548